News Pfizer and Catalia's robot wellness coach aims to help patie... Pfizer and Catalia Health have launched a year-long pilot scheme exploring how patients engage with cute robot companions that use artificial intelligence (AI) to check on symptom managemen
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
